AKT Kinase Inhibitor

CAS No. 842148-40-7

AKT Kinase Inhibitor( —— )

Catalog No. M16130 CAS No. 842148-40-7

An Akt kinase inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 312 In Stock
10MG 537 In Stock
25MG 842 In Stock
50MG 1134 In Stock
100MG 1521 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AKT Kinase Inhibitor
  • Note
    Research use only, not for human use.
  • Brief Description
    An Akt kinase inhibitor.
  • Description
    An Akt kinase inhibitor.
  • In Vitro
    The effect of selective inhibition of Akt in proliferating cells expressing Trop-2 is studied.Akt inhibition, either by silencing or with specific drugs, induces a marked decrease in cell proliferation in cells expressing Trop-2, in a dose-dependent fashion.
  • In Vivo
    Trop-2 expressing tumors subcutaneously injected in animal models show a striking reduction of growth following treatment with specific drugs that inhibit Akt activity. Therefore Akt has a central functional role in mediating the Trop-2-dependent growth stimulus.
  • Synonyms
    ——
  • Pathway
    Cytoskeleton/Cell Adhesion Molecules
  • Target
    Akt
  • Recptor
    Akt
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    842148-40-7
  • Formula Weight
    357.3672
  • Molecular Formula
    C16H19N7O3
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    CCN1C2=C(C(=NC=C2OCCCN)C#CCO)N=C1C3=NON=C3N
  • Chemical Name
    2-Propyn-1-ol, 3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-7-(3-aminopropoxy)-1-ethyl-1H-imidazo[4,5-c]pyridin-4-yl]-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Lenaldekar

    Lenaldekar inhibits T-cell expansion and autoimmune encephalomyelitis.

  • Recilisib

    Recilisib is a radioprotectant,can activate AKT, PI3K activities in cells.

  • AT7867

    AT7867 is a potent, ATP-competitive, orally available dual Akt and p70S6K inhibitor with Ki of 17-85 nM, also inhibits PKA with Ki of 20 nM.